Myron W. Wentz Sells 4,144 Shares of USANA Health Sciences, Inc. (USNA) Stock

USANA Health Sciences, Inc. (NYSE:USNA) Director Myron W. Wentz sold 4,144 shares of USANA Health Sciences stock in a transaction on Wednesday, May 23rd. The shares were sold at an average price of $120.86, for a total transaction of $500,843.84. Following the completion of the sale, the director now directly owns 11,025,753 shares of the company’s stock, valued at approximately $1,332,572,507.58. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.

USANA Health Sciences stock traded down $4.40 on Friday, reaching $112.60. 493,584 shares of the stock were exchanged, compared to its average volume of 154,142. The firm has a market cap of $2.83 billion, a price-to-earnings ratio of 27.73 and a beta of 0.76. USANA Health Sciences, Inc. has a twelve month low of $52.80 and a twelve month high of $121.15.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, April 24th. The company reported $1.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.05 by $0.14. The firm had revenue of $292.00 million during the quarter, compared to analyst estimates of $268.93 million. USANA Health Sciences had a net margin of 6.47% and a return on equity of 27.92%. The business’s revenue was up 14.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.91 EPS. analysts forecast that USANA Health Sciences, Inc. will post 4.4 earnings per share for the current year.

Institutional investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC increased its holdings in shares of USANA Health Sciences by 0.7% during the 4th quarter. Renaissance Technologies LLC now owns 1,930,966 shares of the company’s stock worth $142,988,000 after purchasing an additional 12,700 shares during the period. BlackRock Inc. increased its holdings in shares of USANA Health Sciences by 14.2% during the 1st quarter. BlackRock Inc. now owns 829,290 shares of the company’s stock worth $71,237,000 after purchasing an additional 103,325 shares during the period. Dimensional Fund Advisors LP increased its holdings in shares of USANA Health Sciences by 1.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 777,313 shares of the company’s stock worth $66,771,000 after purchasing an additional 14,692 shares during the period. Teachers Advisors LLC increased its holdings in shares of USANA Health Sciences by 1.2% during the 4th quarter. Teachers Advisors LLC now owns 211,824 shares of the company’s stock worth $15,686,000 after purchasing an additional 2,506 shares during the period. Finally, Matarin Capital Management LLC bought a new position in shares of USANA Health Sciences during the 1st quarter worth about $13,476,000. 48.85% of the stock is owned by hedge funds and other institutional investors.

USNA has been the subject of several analyst reports. TheStreet raised shares of USANA Health Sciences from a “c+” rating to an “a-” rating in a research note on Tuesday, April 24th. ValuEngine raised shares of USANA Health Sciences from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. Finally, Pivotal Research lifted their price objective on shares of USANA Health Sciences from $80.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, February 7th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $95.00.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional and personal care products primarily to reduce the risk of chronic degenerative disease. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include low-glycemic meal replacement shakes, snack bars, and other related products, which provide macro-nutrition.

Insider Buying and Selling by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply